{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T21:01:17Z","timestamp":1782939677696,"version":"3.54.5"},"reference-count":143,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.revmed.2023.03.014","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T18:36:07Z","timestamp":1682102167000},"page":"295-306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Large granular lymphocyte leukemia: An indolent clonal proliferative disease associated with an array of various immunologic disorders"],"prefix":"10.1016","volume":"44","author":[{"given":"G.","family":"Drillet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pastoret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Moignet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Lamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Marchand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.revmed.2023.03.014_bib0710","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1182\/blood-2016-08-692590","article-title":"LGL leukemia: from pathogenesis to treatment","volume":"129","author":"Lamy","year":"2017","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.revmed.2023.03.014_bib0715","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.revmed.2023.03.014_bib0720","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1182\/blood.V75.3.704.704","article-title":"Perforin gene expression in granular lymphocyte proliferative disorders","volume":"75","author":"Oshimi","year":"1990","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.revmed.2023.03.014_bib0725","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2141.1997.d01-2113.x","article-title":"Constitutive expression of Fas ligand in large granular lymphocyte leukaemia","volume":"97","author":"Perzova","year":"1997","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.revmed.2023.03.014_bib0730","first-page":"33","article-title":"Constitutive expression of cytotoxic proteases and down-regulation of protease inhibitors in LGL leukemia","volume":"22","author":"Kothapalli","year":"2003","journal-title":"Int J Oncol"},{"issue":"25","key":"10.1016\/j.revmed.2023.03.014_bib0735","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1182\/blood-2017-09-808816","article-title":"TRAIL mediates and sustains constitutive NF-\u03baB activation in LGL leukemia","volume":"131","author":"Yang","year":"2018","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.revmed.2023.03.014_bib0740","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1189\/jlb.0107073","article-title":"Phenotypic differences between healthy effector CTL and leukemic LGL cells support the notion of antigen-triggered clonal transformation in T-LGL leukemia","volume":"83","author":"Wlodarski","year":"2008","journal-title":"J Leukoc Biol"},{"issue":"8","key":"10.1016\/j.revmed.2023.03.014_bib0750","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1182\/blood-2004-10-4045","article-title":"Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell\u2013receptor restriction in large granular lymphocyte leukemia","volume":"106","author":"Wlodarski","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.revmed.2023.03.014_bib0755","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/s41467-022-29173-z","article-title":"Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia","volume":"13","author":"Huuhtanen","year":"2022","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.revmed.2023.03.014_bib0760","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.leukres.2012.02.001","article-title":"Seroreactivity to LGL leukemia-specific epitopes in aplastic anemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria: Results of a bone marrow failure consortium study","volume":"36","author":"Nyland","year":"2012","journal-title":"Leuk Res"},{"issue":"12","key":"10.1016\/j.revmed.2023.03.014_bib0765","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/blood.V92.12.4771","article-title":"Dysregulation of CD95\/CD95 Ligand-Apoptotic Pathway in CD3+ Large Granular Lymphocyte Leukemia","volume":"92","author":"Lamy","year":"1998","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.revmed.2023.03.014_bib0770","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1182\/blood-2007-06-093823","article-title":"Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia","volume":"111","author":"Yang","year":"2008","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.revmed.2023.03.014_bib0775","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood.2021013164","article-title":"Genomic landscape of TCR\u03b1\u03b2 and TCR\u03b3\u03b4 T-large granular lymphocyte leukemia","volume":"139","author":"Cheon","year":"2022","journal-title":"Blood"},{"issue":"Supplement 1","key":"10.1016\/j.revmed.2023.03.014_bib0780","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood-2020-140695","article-title":"Recurrent mutations of the C-C Motif Chemokine Ligand 22 (CCL22) define a distinct subgroup of chronic lymphoproliferative disorder of NK Cells (CLPD-NK)","volume":"136","author":"Baer","year":"2020","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.revmed.2023.03.014_bib0785","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1182\/blood-2010-01-263145","article-title":"Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome","volume":"115","author":"Dowdell","year":"2010","journal-title":"Blood"},{"issue":"42","key":"10.1016\/j.revmed.2023.03.014_bib0745","doi-asserted-by":"crossref","first-page":"16308","DOI":"10.1073\/pnas.0806447105","article-title":"Network model of survival signaling in large granular lymphocyte F leukemia","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc Natl Acad Sci U.S.A"},{"issue":"1","key":"10.1016\/j.revmed.2023.03.014_bib0790","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/blood-2009-06-223719","article-title":"Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway","volume":"115","author":"Yang","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.revmed.2023.03.014_bib0795","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1182\/blood-2011-04-346759","article-title":"Increased serum soluble IL-15R\u03b1 levels in T-cell large granular lymphocyte leukemia","volume":"119","author":"Chen","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.revmed.2023.03.014_bib0800","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ccr.2012.09.009","article-title":"Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation","volume":"22","author":"Mishra","year":"2012","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.revmed.2023.03.014_bib0805","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1084\/jem.193.2.219","article-title":"Fatal Leukemia in Interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype Cd8+ T cells","volume":"193","author":"Fehniger","year":"2001","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.revmed.2023.03.014_bib0810","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.immuni.2011.09.016","article-title":"A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory","volume":"35","author":"Siegel","year":"2011","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.revmed.2023.03.014_bib0815","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2012.03.014","article-title":"JAK and STAT signaling molecules in immunoregulation and immune-mediated disease","volume":"36","author":"O'Shea","year":"2012","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.revmed.2023.03.014_bib0820","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3390\/ijms22020603","article-title":"The multifaced role of STAT3 in cancer and its implication for anticancer therapy","volume":"22","author":"Tolomeo","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.revmed.2023.03.014_bib0825","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ajhg.2012.02.020","article-title":"Combined analysis of genome-wide association studies for Crohn Disease and psoriasis identifies seven shared susceptibility loci","volume":"90","author":"Ellinghaus","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.revmed.2023.03.014_bib0830","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.immuni.2012.03.016","article-title":"Inborn Errors of Human JAKs and STATs","volume":"36","author":"Casanova","year":"2012","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.revmed.2023.03.014_bib0835","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","article-title":"Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations","volume":"125","author":"Milner","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.revmed.2023.03.014_bib0840","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.immuni.2010.05.003","article-title":"Diverse targets of the transcription factor STAT3 Contribute to T Cell pathogenicity and homeostasis","volume":"32","author":"Durant","year":"2010","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.revmed.2023.03.014_bib0845","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/ecco-jcc\/jjy068","article-title":"Diagnostic yield of next-generation sequencing in very early-onset inflammatory bowel diseases: a multicentre study","volume":"12","author":"Charbit-Henrion","year":"2018","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.revmed.2023.03.014_bib0850","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clim.2017.05.021","article-title":"STAT3 gain-of-function mutations associated with autoimmune lymphoproliferative syndrome like disease deregulate lymphocyte apoptosis and can be targeted by BH3 mimetic compounds","volume":"181","author":"Nabhani","year":"2017","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.revmed.2023.03.014_bib0855","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1172\/JCI9940","article-title":"Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression","volume":"107","author":"Epling-Burnette","year":"2001","journal-title":"J Clin Invest"},{"issue":"20","key":"10.1016\/j.revmed.2023.03.014_bib0860","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","article-title":"Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia","volume":"366","author":"Koskela","year":"2012","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.revmed.2023.03.014_bib0865","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood-2012-06-435297","article-title":"STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia","volume":"120","author":"Jerez","year":"2012","journal-title":"Blood"},{"issue":"Supplement_1","key":"10.1016\/j.revmed.2023.03.014_bib0870","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1182\/blood-2019-123439","article-title":"Prospective, multicentric phase II randomized trial comparing the efficacy of methotrexate or cyclophosphamide in large granular lymphocytic leukemia: a french national study. report on the interim analysis","volume":"134","author":"Lamy","year":"2019","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.revmed.2023.03.014_bib0875","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1182\/blood.2020006721","article-title":"Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells","volume":"137","author":"Pastoret","year":"2021","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.revmed.2023.03.014_bib0880","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41588-022-01059-2","article-title":"CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk","volume":"54","author":"Baer","year":"2022","journal-title":"Nat Genet"},{"issue":"14","key":"10.1016\/j.revmed.2023.03.014_bib0885","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1182\/blood-2013-04-494930","article-title":"STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients","volume":"122","author":"Jerez","year":"2013","journal-title":"Blood"},{"issue":"37","key":"10.1016\/j.revmed.2023.03.014_bib0890","doi-asserted-by":"crossref","first-page":"61876","DOI":"10.18632\/oncotarget.18711","article-title":"STAT3 mutation impacts biological and clinical features of T-LGL leukemia","volume":"8","author":"Teramo","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.revmed.2023.03.014_bib0895","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3324\/haematol.2019.225060","article-title":"Identification of a miR-146b-Fas ligand axis in the development of neutropenia in T large granular lymphocyte leukemia","volume":"105","author":"Mariotti","year":"2020","journal-title":"Haematologica"},{"issue":"57","key":"10.1016\/j.revmed.2023.03.014_bib0900","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1038\/sj.onc.1208122","article-title":"ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL)","volume":"23","author":"Epling-Burnette","year":"2004","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.revmed.2023.03.014_bib0905","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1182\/blood-2005-08-3076","article-title":"Phosphatidylinositol-3-phosphate kinase pathway activation protects leukemic large granular lymphocytes from undergoing homeostatic apoptosis","volume":"107","author":"Schade","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.revmed.2023.03.014_bib0910","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/leu.2017.49","article-title":"Genomic landscape characterization of large granular lymphocyte leukemia with a systems genetics approach","volume":"31","author":"Coppe","year":"2017","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.revmed.2023.03.014_bib0915","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ijc.29697","article-title":"Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia","volume":"138","author":"Johansson","year":"2016","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.revmed.2023.03.014_bib0920","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/gene.2010.64","article-title":"Sequencing of TNFAIP3 and association of variants with multiple autoimmune diseases","volume":"12","author":"Musone","year":"2011","journal-title":"Genes Immun"},{"issue":"25","key":"10.1016\/j.revmed.2023.03.014_bib0925","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1182\/blood-2013-05-503383","article-title":"Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sj\u00f6gren's syndrome","volume":"122","author":"Nocturne","year":"2013","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.revmed.2023.03.014_bib0930","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1182\/blood.2020005831","article-title":"Frequent somatic TET2 mutations in chronic NK-LGL leukemia with distinct patterns of cytopenias","volume":"138","author":"Olson","year":"2021","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.revmed.2023.03.014_bib0935","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3324\/haematol.2009.018481","article-title":"Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases","volume":"95","author":"Bareau","year":"2010","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.revmed.2023.03.014_bib0940","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1309\/PH7X78HF4FW4PRKW","article-title":"T-Cell Large Granular Lymphocyte Leukemias have multiple phenotypic abnormalities involving Pan\u2013T-Cell antigens and receptors for MHC molecules","volume":"124","author":"Lundell","year":"2005","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.revmed.2023.03.014_bib0945","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood.V98.1.165","article-title":"Molecular and flow cytometric analysis of the V\u03b2 repertoire for clonality assessment in mature TCR\u03b1\u03b2 T-cell proliferations","volume":"98","author":"Langerak","year":"2001","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.revmed.2023.03.014_bib0950","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1182\/blood-2003-02-0400","article-title":"Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes","volume":"103","author":"Epling-Burnette","year":"2004","journal-title":"Blood"},{"issue":"40","key":"10.1016\/j.revmed.2023.03.014_bib0955","doi-asserted-by":"crossref","first-page":"42938","DOI":"10.18632\/oncotarget.5480","article-title":"Phenotypic profile of expanded NK cells in chronic lymphoproliferative disorders: a surrogate marker for NK-cell clonality","volume":"6","author":"B\u00e1rcena","year":"2015","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.revmed.2023.03.014_bib0960","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1182\/blood-2002-12-3898","article-title":"Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes","volume":"102","author":"Zambello","year":"2003","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.revmed.2023.03.014_bib0965","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1182\/blood-2012-12-474577","article-title":"Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia","volume":"121","author":"Rajala","year":"2013","journal-title":"Blood"},{"issue":"Supplement 1","key":"10.1016\/j.revmed.2023.03.014_bib0970","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1182\/blood-2020-137269","article-title":"Analysis of genomic landscape of large granular lymphocyte leukemia reveals etiologic insights","volume":"136","author":"Cheon","year":"2020","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.revmed.2023.03.014_bib0985","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/leu.2009.304","article-title":"Chronic lymphoproliferative disorder of natural killer cells: a distinct entity with subtypes correlating with normal natural killer cell subsets","volume":"24","author":"Morice","year":"2010","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.revmed.2023.03.014_bib0990","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2559.2007.02656.x","article-title":"Characteristic appearances of the bone marrow in T-cell large granular lymphocyte leukaemia","volume":"50","author":"Osuji","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.revmed.2023.03.014_bib0995","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.3390\/cancers12102900","article-title":"Cell Leukemia: current state of the art","volume":"12","author":"Hussein","year":"2020","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.revmed.2023.03.014_bib1000","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1093\/annonc\/mdu369","article-title":"Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients","volume":"25","author":"Poullot","year":"2014","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.revmed.2023.03.014_bib1005","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.3390\/cells10102800","article-title":"Neutropenia and large granular lymphocyte leukemia: from pathogenesis to therapeutic options","volume":"10","author":"Calabretto","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.revmed.2023.03.014_bib1010","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1084\/jem.184.2.429","article-title":"Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils","volume":"184","author":"Liles","year":"1996","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.revmed.2023.03.014_bib1015","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1182\/blood.V95.10.3219","article-title":"Chronic neutropenia mediated by Fas ligand","volume":"95","author":"Liu","year":"2000","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.revmed.2023.03.014_bib1020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0037-1963(03)00133-1","article-title":"Clinical features of large granular lymphocyte leukemia","volume":"40","author":"Lamy","year":"2003","journal-title":"Semin Hematol"},{"issue":"4","key":"10.1016\/j.revmed.2023.03.014_bib1025","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1600-0609.2009.01213.x","article-title":"Clinical analysis of 52 patients with granular lymphocyte proliferative disorder (GLPD) showed frequent anemia in indolent T-cell GLPD in Japan","volume":"82","author":"Kawahara","year":"2009","journal-title":"Eur J Haematol"},{"issue":"4","key":"10.1016\/j.revmed.2023.03.014_bib1030","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00277-009-0895-3","article-title":"T-cell large granular lymphocyte leukemia: an Asian perspective","volume":"89","author":"Kwong","year":"2010","journal-title":"Ann Hematol"},{"issue":"10","key":"10.1016\/j.revmed.2023.03.014_bib1035","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1182\/blood.V96.10.3644","article-title":"Lymphoproliferative disease of granular T lymphocytes presenting as aplastic anemia","volume":"96","author":"Go","year":"2000","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.revmed.2023.03.014_bib1040","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1182\/bloodadvances.2018022723","article-title":"Frequent STAT3 mutations in CD8+ T cells from patients with pure red cell aplasia","volume":"2","author":"Kawakami","year":"2018","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.revmed.2023.03.014_bib1045","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1182\/blood.V57.6.1025.1025","article-title":"Pure Red Cell Aplasia and Hypogammaglobulinemia associated With Tr-Cell Chronic Lymphocytic Leukemia","volume":"57","author":"Nagasawa","year":"1981","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.revmed.2023.03.014_bib1050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0145-2126(84)90039-0","article-title":"Acquired pure red-cell aplasia: a consequence of increased natural killer cell activity?","volume":"8","author":"Partanen","year":"1984","journal-title":"Leuk Res"},{"issue":"4","key":"10.1016\/j.revmed.2023.03.014_bib1055","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199901283400405","article-title":"Pure Red-Cell Aplasia Associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors","volume":"340","author":"Handgretinger","year":"1999","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.revmed.2023.03.014_bib1060","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s12185-022-03310-2","article-title":"T cell clonal expansion and STAT3 mutations: a characteristic feature of acquired chronic T cell-mediated pure red cell aplasia","volume":"115","author":"Kawakami","year":"2022","journal-title":"Int J Hematol"},{"issue":"5","key":"10.1016\/j.revmed.2023.03.014_bib1065","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.leukres.2007.08.012","article-title":"Acquired amegakaryocytic thrombocytopenia and pure red cell aplasia associated with an occult large granular lymphocyte leukemia","volume":"32","author":"Lai","year":"2008","journal-title":"Leuk Res"},{"issue":"6","key":"10.1016\/j.revmed.2023.03.014_bib1070","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1038\/s41375-020-01114-z","article-title":"Novel invariant features of Good syndrome","volume":"35","author":"Gurnari","year":"2021","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.revmed.2023.03.014_bib1075","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sj.leu.2403617","article-title":"Large granular lymphocyte (LGL)-like clonal expansions in paroxysmal nocturnal hemoglobinuria (PNH) patients","volume":"19","author":"Risitano","year":"2005","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.revmed.2023.03.014_bib1080","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/s41375-019-0601-y","article-title":"Large granular lymphocytic leukemia coexists with myeloid clones and myelodysplastic syndrome","volume":"34","author":"Durrani","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.revmed.2023.03.014_bib1085","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.leukres.2016.02.006","article-title":"T-cell large granular lymphocyte proliferation in myelodysplastic syndromes: Clinicopathological features and prognostic significance","volume":"43","author":"Zhang","year":"2016","journal-title":"Leuk Res"},{"issue":"11","key":"10.1016\/j.revmed.2023.03.014_bib1090","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1038\/s41375-020-0928-4","article-title":"Characterization of myelodysplastic syndromes (MDS) with T-cell large granular lymphocyte proliferations (LGL)","volume":"34","author":"Komrokji","year":"2020","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.revmed.2023.03.014_bib1095","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3324\/haematol.2017.176701","article-title":"Deep sequencing and flow cytometric characterization of expanded effector memory CD8+CD57+T cells frequently reveals T-cell receptor V\u03b2 oligoclonality and CDR3 homology in acquired aplastic anemia","volume":"103","author":"Giudice","year":"2018","journal-title":"Haematologica"},{"issue":"9431","key":"10.1016\/j.revmed.2023.03.014_bib1100","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(04)16724-X","article-title":"In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR \u03b2-CDR3 sequencing","volume":"364","author":"Risitano","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.revmed.2023.03.014_bib1105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2141.1995.tb05277.x","article-title":"Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia","volume":"91","author":"Maciejewski","year":"1995","journal-title":"Br J Haematol"},{"issue":"25","key":"10.1016\/j.revmed.2023.03.014_bib1110","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1182\/blood-2014-01-549527","article-title":"IFN-\u03b3 causes aplastic anemia by altering hematopoietic stem\/progenitor cell composition and disrupting lineage differentiation","volume":"124","author":"Lin","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.revmed.2023.03.014_bib1115","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/s41375-021-01231-3","article-title":"Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia","volume":"35","author":"Lundgren","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.revmed.2023.03.014_bib1120","doi-asserted-by":"crossref","first-page":"108525","DOI":"10.1016\/j.clim.2020.108525","article-title":"Two siblings presenting with novel ADA2 variants, lymphoproliferation, persistence of large granular lymphocytes, and T-cell perturbations","volume":"218","author":"Saettini","year":"2020","journal-title":"Clin Immunol"},{"issue":"4","key":"10.1016\/j.revmed.2023.03.014_bib1125","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.jaci.2018.01.012","article-title":"ADA2 deficiency: clonal lymphoproliferation in a subset of patients","volume":"141","author":"Trotta","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.revmed.2023.03.014_bib1130","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/ajcp\/aqx146","article-title":"T-Cell Large Granular Lymphocytic Leukemia and Coexisting B-Cell Lymphomas: A Study From the Bone Marrow Pathology Group","volume":"149","author":"Goyal","year":"2018","journal-title":"Am J Clin Pathol."},{"issue":"2","key":"10.1016\/j.revmed.2023.03.014_bib1135","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3109\/10428194.2012.710906","article-title":"Large granular lymphocyte leukemia and lymphomatoid granulomatosis in the same patient: fortuitous association?","volume":"54","author":"Michot","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"10.1016\/j.revmed.2023.03.014_bib1140","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1080\/10428194.2018.1439583","article-title":"Lymphomatoid granulomatosis and large granular lymphocyte leukemia, a rare association of two lymphoproliferative disorders","volume":"59","author":"De Luca","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.revmed.2023.03.014_bib1145","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1016\/j.clml.2014.04.001","article-title":"Report of 6 cases of large granular Lymphocytic Leukemia and Plasma Cell Dyscrasia","volume":"14","author":"Cheng","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"5","key":"10.1016\/j.revmed.2023.03.014_bib1150","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1080\/10428190801932635","article-title":"Chronic B-cell dyscrasias are an important clinical feature of T-LGL leukemia","volume":"49","author":"Viny","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.revmed.2023.03.014_bib1155","doi-asserted-by":"crossref","first-page":"43","DOI":"10.12659\/AJCR.912282","article-title":"A Case of T-Cell Large Granular Lymphocytic Leukemia and renal immunoglobulin heavy chain amyloidosis","volume":"20","author":"Fu","year":"2019","journal-title":"Am J Case Rep"},{"issue":"2","key":"10.1016\/j.revmed.2023.03.014_bib1160","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1179\/1607845415Y.0000000037","article-title":"Gamma heavy chain disease associated with large granular lymphocytic leukemia: A report of two cases and review of the literature","volume":"21","author":"Wahbi","year":"2016","journal-title":"Hematology"},{"issue":"2","key":"10.1016\/j.revmed.2023.03.014_bib1170","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1080\/10428194.2017.1339880","article-title":"Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL)","volume":"59","author":"Sanikommu","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"10.1016\/j.revmed.2023.03.014_bib1165","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ajh.26183","article-title":"Large granular lymphocytic leukemia\u2013A retrospective study of 319 cases","volume":"96","author":"Dong","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2023.03.014_bib1411","doi-asserted-by":"crossref","first-page":"106299","DOI":"10.1016\/j.leukres.2020.106299","article-title":"Clinical features and treatment outcomes in patients with T-cell large granular lymphocytic leukemia: A single-institution experience","volume":"90","author":"Zhu","year":"2020","journal-title":"Leuk Res."},{"issue":"6","key":"10.1016\/j.revmed.2023.03.014_bib1175","doi-asserted-by":"crossref","first-page":"e1140","DOI":"10.1002\/cti2.1140","article-title":"Synovial fluid CD69+CD8+T cells with tissue-resident phenotype mediate perforin-dependent citrullination in rheumatoid arthritis","volume":"9","author":"Jung","year":"2020","journal-title":"Clin Transl Immunol"},{"issue":"4","key":"10.1016\/j.revmed.2023.03.014_bib1180","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s10067-005-0106-0","article-title":"Clinical significance of IL-18, IL-15, IL-12 and TNF-\u03b1 measurement in rheumatoid arthritis","volume":"25","author":"Petrovic-Rackov","year":"2006","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.revmed.2023.03.014_bib1185","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00296-020-04757-4","article-title":"Analysis of a single-institution cohort of patients with Felty's syndrome and T-cell large granular lymphocytic leukemia in the setting of rheumatoid arthritis","volume":"41","author":"Gorodetskiy","year":"2021","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.revmed.2023.03.014_bib1190","doi-asserted-by":"crossref","first-page":"15869","DOI":"10.1038\/ncomms15869","article-title":"Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis","volume":"8","author":"Savola","year":"2017","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.revmed.2023.03.014_bib1195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar2424","article-title":"Characteristics of T-cell large granular lymphocyte proliferations associated with neutropenia and inflammatory arthropathy","volume":"10","author":"Prochorec-Sobieszek","year":"2008","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.revmed.2023.03.014_bib1200","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/sj.leu.2404112","article-title":"TCR\u03b3\u03b4+ large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCR\u03b3\u03b4+ T-cells","volume":"20","author":"Sandberg","year":"2006","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.revmed.2023.03.014_bib1205","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0248-8663(97)89302-2","article-title":"Leuc\u00e9mie \u00e0 grands lymphocytes granuleux T r\u00e9v\u00e9l\u00e9e par une uv\u00e9ite bilat\u00e9rale: association \u00e0 une maladie c\u0153liaque","volume":"18","author":"Molitor","year":"1997","journal-title":"Rev Med Int"},{"issue":"7","key":"10.1016\/j.revmed.2023.03.014_bib1210","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1080\/09273948.2019.1645186","article-title":"Choroidal Infiltration as First Clinical Manifestation of T-cell Large Granular Lymphocyte (T-LGL) Leukemia","volume":"28","author":"Sarny","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"10.1016\/j.revmed.2023.03.014_bib1215","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1182\/blood.V84.5.1620.1620","article-title":"Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance?","volume":"84","author":"Dhodapkar","year":"1994","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.revmed.2023.03.014_bib1220","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajh.10024","article-title":"T-\u03b3 large granular lymphocyte leukemia associated with amegakaryocytic thrombocytopenic purpura, Sj\u00f6gren's syndrome, and polyglandular autoimmune syndrome type II, with subsequent development of pure red cell aplasia","volume":"69","author":"Ergas","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2023.03.014_bib1225","doi-asserted-by":"crossref","first-page":"775313","DOI":"10.3389\/fonc.2021.775313","article-title":"Case report: large Granular Lymphocyte Leukemia (LGLL)\u2014a case series of challenging presentations","volume":"11","author":"Pflug","year":"2022","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.revmed.2023.03.014_bib1230","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.semarthrit.2005.07.001","article-title":"Characterization of T-Cell large granular lymphocyte Leukemia associated with Sjogren's Syndrome\u2014an important but underrecognized association","volume":"35","author":"Friedman","year":"2006","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.revmed.2023.03.014_bib1235","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/s10165-004-0306-5","article-title":"Increased serum interleukin-18 in a patient with systemic lupus erythematosus and T-cell large granular lymphocytic leukemia","volume":"14","author":"Ogata","year":"2004","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.revmed.2023.03.014_bib1240","first-page":"100226","article-title":"Myasthenia Gravis and Large Granular Lymphocytic Leukemia: a rare association","volume":"14","author":"Zhang","year":"2020","journal-title":"Leuk Res Rep"},{"issue":"1","key":"10.1016\/j.revmed.2023.03.014_bib1245","first-page":"32","article-title":"Large granular lymphocytic leukemia associated with Lambert\u2013Eaton Myasthenic Syndrome: A case report","volume":"2","author":"Lemal","year":"2013","journal-title":"Leuk Res Rep"},{"issue":"6","key":"10.1016\/j.revmed.2023.03.014_bib1250","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/mus.10570","article-title":"Myositis in a patient with large granular leukocyte leukemia","volume":"29","author":"Rosche","year":"2004","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.revmed.2023.03.014_bib1255","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/brain\/aww024","article-title":"Association of inclusion body myositis with T cell large granular lymphocytic leukaemia","volume":"139","author":"Greenberg","year":"2016","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.revmed.2023.03.014_bib1260","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1053\/j.gastro.2012.08.028","article-title":"Large granular lymphocytic Leukemia: a treatable form of refractory Celiac disease","volume":"143","author":"Malamut","year":"2012","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.revmed.2023.03.014_bib1265","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1200\/JCO.2008.20.4768","article-title":"Protein-losing enteropathy due to T-Cell large Granular Lymphocyte Leukemia","volume":"27","author":"Hwang","year":"2009","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.revmed.2023.03.014_bib1270","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/gutjnl-2020-322935","article-title":"Oncogenetic landscape of lymphomagenesis in coeliac disease","volume":"71","author":"Cording","year":"2022","journal-title":"Gut"},{"issue":"1\u20132","key":"10.1016\/j.revmed.2023.03.014_bib1275","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/10428190109057973","article-title":"T-Large Granular Lymphocyte Leukemia Accompanied by an Increase of Natural Killer Cells (CD3-) and Associated with Ulcerative Colitis and Autoimmune Hepatitis","volume":"41","author":"Kondo","year":"2001","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1016\/j.revmed.2023.03.014_bib1280","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.chest.2020.07.094","article-title":"Large Granular Lymphocyte Leukemia and Precapillary Pulmonary Hypertension","volume":"158","author":"Cherel","year":"2020","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.revmed.2023.03.014_bib1285","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2133.2007.08035.x","article-title":"Cutaneous vasculitis and T-large granular lymphocyte leukaemia with parallel evolution","volume":"157","author":"Meyer","year":"2007","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.revmed.2023.03.014_bib1290","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.semarthrit.2013.07.002","article-title":"Vasculitis associated with large granular lymphocyte (LGL) leukemia: presentation and treatment outcomes of 11 cases","volume":"43","author":"Audemard","year":"2013","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.revmed.2023.03.014_bib1295","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.ekir.2021.01.024","article-title":"Natural killer cell large granular Lymphocyte Leukemia-Induced Glomerulonephritis","volume":"6","author":"Isnard","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.revmed.2023.03.014_bib1300","doi-asserted-by":"crossref","unstructured":"Zhao T, Hu N, Yu X, Su T. Case Report: Endocapillary Glomerulopathy Associated With Large Granular T Lymphocyte Leukemia. Front Immunol;12:810223","DOI":"10.3389\/fimmu.2021.810223"},{"issue":"31","key":"10.1016\/j.revmed.2023.03.014_bib1305","doi-asserted-by":"crossref","first-page":"e16649","DOI":"10.1097\/MD.0000000000016649","article-title":"Recurrent anti-GBM disease with T-cell large granular lymphocytic leukemia","volume":"98","author":"Zhang","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.revmed.2023.03.014_bib1310","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/cup.13860","article-title":"CD8-positive cutaneous lymphoproliferation associated with large granular lymphocyte leukemia in a patient with X-linked agammaglobulinemia","volume":"48","author":"Daou","year":"2021","journal-title":"J Cutan Pathol"},{"issue":"1","key":"10.1016\/j.revmed.2023.03.014_bib1315","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jns.2005.01.013","article-title":"Peripheral neuropathy associated with chronic natural killer cell lymphocytosis","volume":"232","author":"Noguchi","year":"2005","journal-title":"J Neurol Sci"},{"issue":"14","key":"10.1016\/j.revmed.2023.03.014_bib1320","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1182\/blood-2008-07-168245","article-title":"A critical role for DAP10 and DAP12 in CD8+ T cell-mediated tissue damage in large granular lymphocyte leukemia","volume":"113","author":"Chen","year":"2009","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.revmed.2023.03.014_bib1412","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1046\/j.1365-4362.2002.01671.x","article-title":"Cutaneous findings associated with chronic natural killer cell lymphocytosis","volume":"41","author":"Vanness","year":"2002","journal-title":"Int J Dermatol."},{"issue":"4","key":"10.1016\/j.revmed.2023.03.014_bib0975","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/s41375-019-0644-0","article-title":"Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients","volume":"34","author":"Baril\u00e0","year":"2020","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.revmed.2023.03.014_bib0980","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s12185-019-02625-x","article-title":"STAT3 mutations in natural killer cells are associated with cytopenia in patients with chronic lymphoproliferative disorder of natural killer cells","volume":"109","author":"Kawakami","year":"2019","journal-title":"Int J Hematol"},{"issue":"4","key":"10.1016\/j.revmed.2023.03.014_bib1325","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/leu.2014.298","article-title":"Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998)","volume":"29","author":"Loughran","year":"2015","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.revmed.2023.03.014_bib1330","doi-asserted-by":"crossref","first-page":"e0130078","DOI":"10.1371\/journal.pone.0130078","article-title":"Methotrexate is a JAK\/STAT Pathway inhibitor","volume":"10","author":"Thomas","year":"2015","journal-title":"PLOS ONE"},{"issue":"5","key":"10.1016\/j.revmed.2023.03.014_bib1335","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/leu.2013.359","article-title":"Cyclophosphamide as a first-line therapy in LGL leukemia","volume":"28","author":"Moignet","year":"2014","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.revmed.2023.03.014_bib1340","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3324\/haematol.11192","article-title":"Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study group","volume":"92","author":"Sawada","year":"2007","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.revmed.2023.03.014_bib1345","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.leukres.2013.01.017","article-title":"Treatment of T-cell large granular lymphocyte leukemia with cyclosporine A: Experience in a Chinese single institution","volume":"37","author":"Zhao","year":"2013","journal-title":"Leuk Res"},{"issue":"3","key":"10.1016\/j.revmed.2023.03.014_bib1350","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1365-2133.2012.11168.x","article-title":"Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study","volume":"167","author":"Papp","year":"2012","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.revmed.2023.03.014_bib1355","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1056\/NEJMoa1112168","article-title":"Tofacitinib, an oral janus kinase inhibitor, in active ulcerative colitis","volume":"367","author":"Sandborn","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.revmed.2023.03.014_bib1360","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJMoa1109071","article-title":"Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis","volume":"367","author":"Fleischmann","year":"2012","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.revmed.2023.03.014_bib1365","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1038\/leu.2015.280","article-title":"Tofacitinib as a novel salvage therapy for refractory T-cell large granular lymphocytic leukemia","volume":"29","author":"Bilori","year":"2015","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.revmed.2023.03.014_bib1370","doi-asserted-by":"crossref","first-page":"E368","DOI":"10.1002\/ajh.26275","article-title":"Ruxolitinib for refractory large granular lymphocyte leukemia","volume":"96","author":"Moignet","year":"2021","journal-title":"Am J Hematol"},{"issue":"Supplement_1","key":"10.1016\/j.revmed.2023.03.014_bib1375","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1182\/blood-2019-129291","article-title":"Blockade of IL-15 utilizing Bnz-1, a selective \u03b3-Chain inhibiting peptide, is safe and has clinical activity in patients with T-Cell large granular Lymphocytic Leukemia (T-LGLL): Results of a phase I\/II multi-center clinical trial","volume":"134","author":"Brammer","year":"2019","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.revmed.2023.03.014_bib1380","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/s41375-018-0290-y","article-title":"IL-2 and IL-15 blockade by BNZ-1, an inhibitor of selective \u03b3-chain cytokines, decreases leukemic T-cell viability","volume":"33","author":"Wang","year":"2019","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.revmed.2023.03.014_bib1385","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1016\/S2352-3026(15)00227-6","article-title":"Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study","volume":"3","author":"Dumitriu","year":"2016","journal-title":"Lancet Haematol"},{"issue":"2","key":"10.1016\/j.revmed.2023.03.014_bib1390","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1080\/10428194.2017.1339880","article-title":"Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL)","volume":"59","author":"Sanikommu","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"10.1016\/j.revmed.2023.03.014_bib1395","doi-asserted-by":"crossref","first-page":"e04533","DOI":"10.1002\/ccr3.4533","article-title":"A non-cytotoxic regimen of decitabine to treat refractory T-cell large granular lymphocytic leukemia","volume":"9","author":"Zawit","year":"2021","journal-title":"Clin Case Rep"},{"issue":"22","key":"10.1016\/j.revmed.2023.03.014_bib1400","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood.V128.22.113.113","article-title":"Characterization of Myelodysplastic Syndromes (MDS) with T-Cell Large Granular Lymphocyte Proliferations (LGL)","volume":"128","author":"Roe","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2023.03.014_bib1405","first-page":"80","article-title":"Prolonged complete hematologic response in relapsed\/refractory T-large granular lymphocyte leukemia after bendamustine treatment","volume":"15","author":"Rosamilio","year":"2016","journal-title":"Transl Med UniSa"},{"issue":"5","key":"10.1016\/j.revmed.2023.03.014_bib1410","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/leu.2015.256","article-title":"Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation","volume":"30","author":"Marchand","year":"2016","journal-title":"Leukemia"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866323001194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866323001194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:46:40Z","timestamp":1759337200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866323001194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":143,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0248866323001194"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2023.03.014","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Large granular lymphocyte leukemia: An indolent clonal proliferative disease associated with an array of various immunologic disorders","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2023.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI).","name":"copyright","label":"Copyright"}]}}